Viewing Study NCT06316856


Ignite Creation Date: 2025-12-24 @ 11:35 PM
Ignite Modification Date: 2026-03-30 @ 12:13 PM
Study NCT ID: NCT06316856
Status: RECRUITING
Last Update Posted: 2025-11-26
First Post: 2024-03-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: CD5 Chimeric Antigen Receptor (CAR) T Cells in Subjects With Relapsed or Refractory T-cell Malignancies
Sponsor: Beijing GoBroad Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None T-Cell Acute Lymphocytic Leukemia View
None Acute Lymphoblastic Leukemia, in Relapse View
None Refractory Acute Lymphoblastic Leukemia View
None T-cell Malignancies View
Keywords: